Evidence map›Paper›PMID 26433376›Full record

ArticleMolecular neurobiology2016

Sulforaphane Ameliorates Okadaic Acid-Induced Memory Impairment in Rats by Activating the Nrf2/HO-1 Antioxidant Pathway.

Subhash Dwivedi, N Rajasekar, Kashif Hanif, Chandishwar Nath, Rakesh Shukla

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Lithium promotes recovery after spinal cord injury.Neural regeneration research · 2022
    Article
  13. Sulforaphane Induces Glioprotection After LPS Challenge.Cellular and molecular neurobiology · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Subhash DwivediDivision of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
N RajasekarDivision of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
Kashif HanifDivision of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
Chandishwar NathDivision of Toxicology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
Rakesh ShuklaDivision of Pharmacology, CSIR-Central Drug Research Institute, Lucknow, 226031, India. rakeshshuklacdri@gmail.com.
Central Drug Research Institute · INAcademy of Scientific and Innovative Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Okadaic acid (OKA) causes memory impairment and attenuates nuclear factor erythroid 2-related factor 2 (Nrf2) along with oxidative stress and neuroinflammation in rats. Sulforaphane (dietary isothiocyanate compound), an activator of Nrf2 signaling, exhibits neuroprotective effects. However, the protective effect of sulforaphane in OKA-induced neurotoxicity remains uninvestigated. Therefore, in the present study, the role of sulforaphane in OKA-induced memory impairment in rats was explored. A significant increased Nrf2 expression in the hippocampus and cerebral cortex was observed in trained (Morris water maze) rats, and a significant decreased Nrf2 expression in memory-impaired (OKA, 200 ng icv) rats indicated its involvement in memory function. Sulforaphane administration (5 and 10 mg/kg, ip, days 1 and 2) ameliorates OKA-induced memory impairment in rats. The treatment also restored Nrf2 and its downstream antioxidant protein expression (GCLC, HO-1) and attenuated oxidative stress (ROS, nitrite, GSH), neuroinflammation (NF-κB, TNF-α, IL-10), and neuronal apoptosis in the cerebral cortex and hippocampus of OKA-treated rats. Further, to determine whether modulation of Nrf2 signaling is responsible for the protective effect of sulforaphane, in vitro, Nrf2 siRNA and its downstream HO-1 inhibition studies were carried out in a rat astrocytoma cell line (C6). The protective effects of sulforaphane were abolished with Nrf2 siRNA and HO-1 inhibition in astrocytes. The results suggest that Nrf2-dependent activation of cellular antioxidant machinery results in sulforaphane-mediated protection against OKA-induced memory impairment in rats. Graphical Abstract ᅟ.

Indexed as

Signal TransductionAnimalsAntioxidantsApoptosisBiomarkersCell Line, TumorCell SurvivalGlutamate-Cysteine LigaseGlutathioneHeme Oxygenase-1InflammationIsothiocyanatesMaleMaze LearningMemory DisordersMotor ActivityAntioxidantsBiomarkersGCLC protein, ratGlutamate-Cysteine LigaseGlutathioneHeme Oxygenase-1IsothiocyanatesNeuroprotective AgentsNF-E2-Related Factor 2Okadaic AcidProtoporphyrinsReactive Oxygen SpeciesRNA, MessengerRNA, Small InterferingsulforaphaneSulfoxideszinc protoporphyrinAstrocytesMemory impairmentNeuroinflammationNrf2Okadaic acidSulforaphane

Identifiers

PMID26433376
OpenAlexW2179397434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.